Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir

Files
Overton2010Metabolic-CCBY.pdf (191.53 KB)
Date
2010-11-08
Authors
Overton, T.
Aberg, J. A.
Gupta, S.
Ryan, R.
Baugh, B.
De La Rosa, G.
Language
American English
Embargo Lift Date
Department
Medicine, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Wiley
Abstract
Description
Keywords
Protease inhibitors, Metabolic complications, Cardiovascular risk, HIV infection, Darunavir/ritonavir (DRV/r) based therapy, Atazanavir/ritonavir (ATV/r) based therapy
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Overton T, Aberg JA, Gupta S, Ryan R, Baugh B, De La Rosa G. Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir. J Int AIDS Soc. 2010;13(Suppl 4):P74. Published 2010 Nov 8. doi:10.1186/1758-2652-13-S4-P74
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Journal of the International AIDS Society
Rights
Attribution 4.0 International Creative Commons licenses
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/46240
DOI
https://doi.org/10.1186/1758-2652-13-S4-P74
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles